docosapentaenoic-acid and resolvin-D4

docosapentaenoic-acid has been researched along with resolvin-D4* in 1 studies

Other Studies

1 other study(ies) available for docosapentaenoic-acid and resolvin-D4

Article	Year
Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis. Nature communications, 2020, 10-27, Volume: 11, Issue:1 Biomarkers are needed for predicting the effectiveness of disease modifying antirheumatic drugs (DMARDs). Here, using functional lipid mediator profiling and deeply phenotyped patients with early rheumatoid arthritis (RA), we observe that peripheral blood specialized pro-resolving mediator (SPM) concentrations are linked with both DMARD responsiveness and disease pathotype. Machine learning analysis demonstrates that baseline plasma concentrations of resolvin D4, 10S, 17S-dihydroxy-docosapentaenoic acid, 15R-Lipoxin (LX)A Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Humans; Lipoxins; Synovial Fluid; Treatment Outcome	2020

Article

Year

Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis.

Nature communications, 2020, 10-27, Volume: 11, Issue:1

Biomarkers are needed for predicting the effectiveness of disease modifying antirheumatic drugs (DMARDs). Here, using functional lipid mediator profiling and deeply phenotyped patients with early rheumatoid arthritis (RA), we observe that peripheral blood specialized pro-resolving mediator (SPM) concentrations are linked with both DMARD responsiveness and disease pathotype. Machine learning analysis demonstrates that baseline plasma concentrations of resolvin D4, 10S, 17S-dihydroxy-docosapentaenoic acid, 15R-Lipoxin (LX)A

Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Humans; Lipoxins; Synovial Fluid; Treatment Outcome

2020